News und Analysen

Just after market close on Monday, Amentum Holdings (NYSE: AMTM) posted its latest set of quarterly figures. This led to a bull stampede into the stock the following day, with eager investors

Most investors considering artificial intelligence (AI) stocks gravitate toward big names such as Nvidia, Broadcom, Advanced Micro Devices, and hyperscalers building large AI clusters. However

You may have noticed that the markets are exceptionally volatile at the moment. That's true whether we're talking about stocks, cryptocurrencies, or commodities.

During turbulent times, many

In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD). To learn more, check out the short video, consider subscribing, and click the special offer link below.

This year hasn't been the easiest for UnitedHealth Group (NYSE: UNH). The biggest U.S. health insurer has faced several challenges, from the unexpected departure of its chief executive officer back

Health insurer Centene (NYSE: CNC) is helping lead the stock market higher this morning, rising 8% through 11:05 a.m. on positive healthcare news out of Washington, D.C.:

It looks like Obamacare

Nanobiotix (NASDAQ: NBTX) is a French biotechnology stock, and one that has soared 660% in 2025 as of Nov. 18. That's enough to draw investor attention, and to have many wondering if such torrid

Investors who are looking for high-potential artificial intelligence (AI) stocks often pick well-known semiconductor players such as Nvidia and Advanced Micro Devices, hyperscalers such as Amazon

After climbing 2.3% in October, the S&P 500 has taken a U-turn and driven steadily lower over the past few weeks. From the start of November through Nov. 21, the index has dipped about 3.5%.

But

The wave of crypto optimism we've seen this year hasn't done much for Cardano (CRYPTO: ADA). The smart contract crypto's price is down 50% year over year and, at $0.41, is worth about 86% less than

It's been a good year for Medtronic (NYSE: MDT), a medical device specialist. Despite the threat of tariffs, the healthcare leader has generally delivered strong financial results and has

Dividend Kings are the royalty of dividend stocks. These companies have increased their payments every single year for half a century. It's an elite group, with only 56 companies currently meeting

Carnival (NYSE: CCL) has drawn investor interest for many reasons. Travel stocks remain popular, and the company's market lead in the cruise line industry and the continued strength in bookings

AstraZeneca (NASDAQ: AZN) stock finished the trading week in style, rising by nearly 3% in value on Friday. That was due to news from the company that it's expanding its manufacturing footprint in

The past five years have been a roller-coaster ride for Pfizer (NYSE: PFE). The pharmaceutical giant shook up its business -- for instance, by getting rid of its off-patent drug unit -- and made a

Dividend-paying stocks are great for the passive income they provide to those who choose to take their payouts in cash, and also for the opportunity to boost the long-term returns of those who

Do you want to swing for the fences with a promising growth stock to buy and hold? While many growth stocks may seem overpriced these days, you can find some decently priced mid-cap stocks, whose

If you invest for the long term and are willing to be patient, you can generate life-changing returns. As long as you have the mindset that you're buying and holding for the future rather than

Shares of Exact Sciences (NASDAQ: EXAS) climbed on Thursday after the medical diagnostics specialist agreed to be acquired by Abbott (NYSE: ABT) for $21 billion.

As of 2:30 p.m. EST, Exact

On November 14, 2025, Bain Capital Life Sciences Investors, LLC disclosed a purchase of 520,310 shares of Cidara Therapeutics (NASDAQ:CDTX), increasing its position value by approximately $167.48

Over the past two years, Merck (NYSE: MRK) has faced several challenges, resulting in a decline in the company's share price. Even worse, the pharmaceutical giant could face more issues ahead

Healthcare giant Pfizer (NYSE: PFE) has been offering a high yield for some time. But that hasn't been enough to get investors to buy up the stock. You can see that in its sluggish share price, and

Just prior to last week's takeover news, Cidara Therapeutics (NASDAQ: CDTX) was already one of the year's top-performing stocks. Trading in the mid-$20s at the start of 2025, by mid-November, this